Asian Hydropower has released a notice regarding issuing IPO shares to residents of the Ilam district and Nepalese working abroad from Mangsir 27.
Notice Date: Dec 5, 2022
To offer the people of the Ilam District who would be impacted by the project an Initial Public Offering (IPO). A letter of offer has been made available by Asian Hydropower Limited for Nepalese people working abroad. For locals and Nepalese citizens living abroad, the initial public offering (IPO) will start on Mangsir 27 and terminate on Poush 12 in 2079. It is important to emphasize to Ilam District inhabitants that if the early closing date is not met, the problem might not be resolved until the 27th Poush. The issue won’t persist through the early deadline for Nepalese nationals working abroad, though.
All about Asian Hydropower is distributing IPO shares to locals and Nepalese living abroad.
10%, or Rs. 3.4 crore of the company’s issued capital, or Rs. 34 crores, is available for use. 3,40,000 unit shares have been distributed to project-affected Ilam District residents. 8,40,000 unit shares, or 24.71% of the company’s issued capital, will eventually be distributed to the general public. 10% of the 84,000 shares, or 84,000 units, of this public sale, will be distributed to Nepalese people working overseas. The date mentioned above marks the start of trading for the issue.
A minimum of 10 units must submit to be considered. Additionally, residents impacted by the project and Nepalese nationals working abroad should submit a combined total of 20,000 units. This IPO’s issue manager is NMB Capital Ltd.
“CARE-NP BB (Is)” is the issuer rating that CARE Ratings Nepal Limited (CRNL) previously assigned to Asian Hydropower Limited. Issuers with this grade are thought to have a modest risk of default regarding the timely payment of financial obligations in Nepal. Asian Hydropower Ltd. was founded on May 5, 2016, and it first began as a private limited business. On July 10, 2019, it became a public limited company.
For more contents please follow, Wapnepal.